Clinical trial
Treatment of Spastic Equinovarus Foot After Stroke
NCT00199589 · University Hospital, Limoges, Other · Completed
Key facts
| NCT number | NCT00199589 |
|---|---|
| Title | Treatment of Spastic Equinovarus Foot After Stroke |
| Official title | Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection |
| Lead sponsor | University Hospital, Limoges, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Spastic Equinovarus |
| Intervention type | Drug |
| Interventions | Botulinic toxin (Botox) |
| Enrollment | 46 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 30, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: